Home/Filings/4/0001641172-25-019858
4//SEC Filing

Cashmere Karen A. 4

Accession 0001641172-25-019858

CIK 0001859007other

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 12:55 PM ET

Size

5.8 KB

Accession

0001641172-25-019858

Insider Transaction Report

Form 4
Period: 2025-07-11
Cashmere Karen A.
Chief Commercial Officer
Transactions
  • Award

    Stock Options

    2025-07-11+48,10048,100 total
    Exercise: $0.59Exp: 2035-07-11Common Stock (48,100 underlying)
Footnotes (2)
  • [F1]This Form 4 is being filed late as the result of an inadvertent administrative oversight.
  • [F2]The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

ZyVersa Therapeutics, Inc.

CIK 0001859007

Entity typeother

Related Parties

1
  • filerCIK 0001954546

Filing Metadata

Form type
4
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 12:55 PM ET
Size
5.8 KB